Central nervous system therapeutic (CNS) market is anticipated to grow at a CAGR of 7.5% during the forecast period. Central nervous system disorder is a neurological disease that directly affects the functioning of the brain or spinal cord and other body parts. Stroke, Alzheimer’s Disease, spinal cord disorders, and Parkinson’s disease are some common central nervous system disorders. The rising prevalence of Parkinson’s disease across the globe is contributing to the growth of the global central nervous system therapeutics market. According to the data provided by Parkinson’s Foundation, around 1 million people in the US have Parkinson’s disease, and also it is expected to rise to 1.2 million by 2030. Additionally, every year in the US around 60,000 people are diagnosed with this disease. This, in turn, is driving the demand for medications used for the treatment of Parkinson’s diseases and thereby driving the market growth.
Get Free Sample link @ https://www.omrglobal.com/request-sample/central-nervous-system-therapeutic-market
The global central nervous system therapeutic market is segmented based on indication, application, and drug class. Based on the disease, the market is segmented into neurovascular diseases, CNS trauma, mental health, neurodegenerative diseases, infectious diseases and cancer. Based on the application, the market is segmented into hospital & clinics, homecare, and others. Based on drug class, the market is segmented into immunomodulatory drugs, interferons, decarboxylase inhibitors, dopamine agonists, antidepressants, and others. The above mentioned segments can be customized as per the requirements.
A full report of Central Nervous System Therapeutic Market available @ https://www.omrglobal.com/industry-reports/central-nervous-system-therapeutic-market
Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Central Nervous System Therapeutics Market by Indication
- Neurovascular Diseases
- CNS Trauma
- Mental Health
- Neurodegenerative Diseases
- Infectious Diseases
- Cancer
Global Central Nervous System Therapeutic Market by Application
- Hospitals and Clinics
- Homecare
- Others
Global Central Nervous System Therapeutic Market by Drug Class
- Immunomodulatory Drugs
- Interferons
- Decarboxylase Inhibitors
- Dopamine Agonists
- Antidepressants
- Others
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- AstraZeneca plc
- Cipla Ltd.
- CNS Pharmaceuticals, Inc.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Lundbeck A/S
- Lupin Ltd.
- Medopharm Private Ltd.
- Neurelis, Inc.
- Nuventra Pharma Sciences
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.
- Sanofi S.A.
- Shire plc
- Teva Pharmaceutical Industries Ltd.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global central nervous system therapeutic market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/central-nervous-system-therapeutic-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
